140 related articles for article (PubMed ID: 29945706)
1. [Bioinformatics Analysis of DNA Methylation in the Promoters of LincRNA
in Lung Adenocarcinoma].
Zhang W; Li S; Guo N; Zhao Y
Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):470-475. PubMed ID: 29945706
[TBL] [Abstract][Full Text] [Related]
2. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
[TBL] [Abstract][Full Text] [Related]
3. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
5. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
[TBL] [Abstract][Full Text] [Related]
6. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.
Li Q; Chen C; Ren X; Sun W
Oncotarget; 2017 May; 8(20):33100-33109. PubMed ID: 28380439
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of Lung Adenocarcinoma.
Tian W; Li YS; Zhang JH; Li JJ; Gao JH
DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
10. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
11. LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.
Castellano JJ; Navarro A; Viñolas N; Marrades RM; Moises J; Cordeiro A; Saco A; Muñoz C; Fuster D; Molins L; Ramirez J; Monzo M
J Thorac Oncol; 2016 Dec; 11(12):2173-2182. PubMed ID: 27496652
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide DNA Methylation Profiling in Early Stage I Lung Adenocarcinoma Reveals Predictive Aberrant Methylation in the Promoter Region of the Long Noncoding RNA PLUT: An Exploratory Study.
Kim-Wanner SZ; Assenov Y; Nair MB; Weichenhan D; Benner A; Becker N; Landwehr K; Kuner R; Sültmann H; Esteller M; Koch I; Lindner M; Meister M; Thomas M; Bieg M; Klingmüller U; Schlesner M; Warth A; Brors B; Seifried E; Bönig H; Plass C; Risch A; Muley T
J Thorac Oncol; 2020 Aug; 15(8):1338-1350. PubMed ID: 32272161
[TBL] [Abstract][Full Text] [Related]
13. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
Shiba-Ishii A; Noguchi M
Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
[TBL] [Abstract][Full Text] [Related]
14. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
16. Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.
Lenka G; Tsai MH; Lin HC; Hsiao JH; Lee YC; Lu TP; Lee JM; Hsu CP; Lai LC; Chuang EY
Sci Rep; 2017 Feb; 7():42573. PubMed ID: 28198450
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation signatures of long intergenic noncoding RNAs in porcine adipose and muscle tissues.
Zhou ZY; Li A; Wang LG; Irwin DM; Liu YH; Xu D; Han XM; Wang L; Wu SF; Wang LX; Xie HB; Zhang YP
Sci Rep; 2015 Oct; 5():15435. PubMed ID: 26493951
[TBL] [Abstract][Full Text] [Related]
18. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of
Hu S; Zhang W; Ye J; Zhang Y; Zhang D; Peng J; Yu D; Xu J; Wei Y
Aging (Albany NY); 2021 Dec; 13(24):25799-25845. PubMed ID: 34910688
[TBL] [Abstract][Full Text] [Related]
20. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
